These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

269 related articles for article (PubMed ID: 27521321)

  • 41. Chemotherapy Options for Poor Responders to Neoadjuvant Chemotherapy for Orbital Granulocytic Sarcoma.
    Gossai N; Cafferty R; Weigel B
    Curr Treat Options Oncol; 2016 Jul; 17(7):38. PubMed ID: 27300546
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Prognostic significance of flow-cytometry evaluation of minimal residual disease in children with acute myeloid leukaemia treated according to the AIEOP-AML 2002/01 study protocol.
    Buldini B; Rizzati F; Masetti R; Fagioli F; Menna G; Micalizzi C; Putti MC; Rizzari C; Santoro N; Zecca M; Disarò S; Rondelli R; Merli P; Pigazzi M; Pession A; Locatelli F; Basso G
    Br J Haematol; 2017 Apr; 177(1):116-126. PubMed ID: 28240765
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Induction therapy in acute myeloid leukemia: intensifying and targeting the approach.
    Fernandez HF; Rowe JM
    Curr Opin Hematol; 2010 Mar; 17(2):79-84. PubMed ID: 20087177
    [TBL] [Abstract][Full Text] [Related]  

  • 44. What is the optimal therapy for childhood AML?
    Loeb DM; Arceci RJ
    Oncology (Williston Park); 2002 Aug; 16(8):1057-66; discussion 1066, 1068-70. PubMed ID: 12201645
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Molecular Changes During Acute Myeloid Leukemia (AML) Evolution and Identification of Novel Treatment Strategies Through Molecular Stratification.
    Karjalainen E; Repasky GA
    Prog Mol Biol Transl Sci; 2016; 144():383-436. PubMed ID: 27865463
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Acute Myeloid Leukemia (AML): different treatment strategies versus a common standard arm--combined prospective analysis by the German AML Intergroup.
    Büchner T; Schlenk RF; Schaich M; Döhner K; Krahl R; Krauter J; Heil G; Krug U; Sauerland MC; Heinecke A; Späth D; Kramer M; Scholl S; Berdel WE; Hiddemann W; Hoelzer D; Hehlmann R; Hasford J; Hoffmann VS; Döhner H; Ehninger G; Ganser A; Niederwieser DW; Pfirrmann M
    J Clin Oncol; 2012 Oct; 30(29):3604-10. PubMed ID: 22965967
    [TBL] [Abstract][Full Text] [Related]  

  • 47. High prognostic impact of flow cytometric minimal residual disease detection in acute myeloid leukemia: data from the HOVON/SAKK AML 42A study.
    Terwijn M; van Putten WL; Kelder A; van der Velden VH; Brooimans RA; Pabst T; Maertens J; Boeckx N; de Greef GE; Valk PJ; Preijers FW; Huijgens PC; Dräger AM; Schanz U; Jongen-Lavrecic M; Biemond BJ; Passweg JR; van Gelder M; Wijermans P; Graux C; Bargetzi M; Legdeur MC; Kuball J; de Weerdt O; Chalandon Y; Hess U; Verdonck LF; Gratama JW; Oussoren YJ; Scholten WJ; Slomp J; Snel AN; Vekemans MC; Löwenberg B; Ossenkoppele GJ; Schuurhuis GJ
    J Clin Oncol; 2013 Nov; 31(31):3889-97. PubMed ID: 24062400
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Is it time to change conventional consolidation chemotherapy for acute myeloid leukemia in CR1?
    Wolach O; Stone RM
    Curr Opin Hematol; 2015 Mar; 22(2):123-31. PubMed ID: 25594168
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Is it time to use minimal residual disease to stratify post-remission treatment for acute myeloid leukemia?
    Liu H; Stock W
    Leuk Lymphoma; 2015; 56(11):3005-7. PubMed ID: 25944470
    [No Abstract]   [Full Text] [Related]  

  • 50. Upfront therapy of acute myeloid leukemia.
    Canzoniero JV; Bhatnagar B; Baer MR; Gojo I
    Curr Oncol Rep; 2011 Oct; 13(5):361-70. PubMed ID: 21725902
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Minimal residual disease in acute myeloid leukemia: coming of age.
    Paietta E
    Hematology Am Soc Hematol Educ Program; 2012; 2012():35-42. PubMed ID: 23233558
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Ab therapy of AML: native anti-CD33 Ab and drug conjugates.
    Jurcic JG
    Cytotherapy; 2008; 10(1):7-12. PubMed ID: 17917880
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Pediatric acute myeloid leukemia: Insight into genetic landscape and novel targeted approaches.
    Tosic N; Marjanovic I; Lazic J
    Biochem Pharmacol; 2023 Sep; 215():115705. PubMed ID: 37532055
    [TBL] [Abstract][Full Text] [Related]  

  • 54. A User's Guide to Novel Therapies for Acute Myeloid Leukemia.
    Patel SA; Gerber JM
    Clin Lymphoma Myeloma Leuk; 2020 May; 20(5):277-288. PubMed ID: 32113891
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Revisiting maintenance therapy in acute myeloid leukemia with novel agents.
    Canaani J; Luger SM
    Curr Opin Hematol; 2016 Mar; 23(2):175-80. PubMed ID: 26766539
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Is there a role for maintenance therapy in acute myeloid leukaemia?
    Baer MR
    Best Pract Res Clin Haematol; 2009 Dec; 22(4):517-21. PubMed ID: 19959102
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Competitive CBFbeta/MYH11 reverse-transcriptase polymerase chain reaction for quantitative assessment of minimal residual disease during postremission therapy in acute myeloid leukemia with inversion(16): a pilot study.
    Laczika K; Novak M; Hilgarth B; Mitterbauer M; Mitterbauer G; Scheidel-Petrovic A; Scholten C; Thalhammer-Scherrer R; Brugger S; Keil F; Schwarzinger I; Haas OA; Lechner K; Jaeger U
    J Clin Oncol; 1998 Apr; 16(4):1519-25. PubMed ID: 9552061
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Challenges in the diagnosis and treatment of secondary acute myeloid leukemia.
    Ossenkoppele G; Montesinos P
    Crit Rev Oncol Hematol; 2019 Jun; 138():6-13. PubMed ID: 31092386
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Molecularly targeted therapy in acute myeloid leukemia.
    Gill H; Leung AY; Kwong YL
    Future Oncol; 2016 Mar; 12(6):827-38. PubMed ID: 26828965
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Are adjuncts to induction chemotherapy worthwhile in the treatment of acute myeloid leukemia?
    Ravandi F
    Best Pract Res Clin Haematol; 2014; 27(3-4):241-6. PubMed ID: 25455273
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.